BRIGHTPATH Trademark

Trademark Overview


On Wednesday, April 5, 2017, a trademark application was filed for BRIGHTPATH with the United States Patent and Trademark Office. The USPTO has given the BRIGHTPATH trademark a serial number of 79213672. The federal status of this trademark filing is PARTIAL SECTION 71 & 15 ACCEPTED AND ACKNOWLEDGED as of Wednesday, June 12, 2024. This trademark is owned by GreenPeptide Co., Ltd.. The BRIGHTPATH trademark is filed in the Pharmaceutical Products, Medical Instrument Products, Advertising, Business and Retail Services, and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations for the prevention and treatment of cancer

[ Retail store services or wholesale store services relating to pharmaceutical preparations and medical supplies; retail store services or wholesale store services relating to medical apparatus and instruments ]

[ Medical apparatus and instruments, namely, medical syringe connector ]

Conducting clinical trials for others; testing, inspection or research of pharmaceuticals
brightpath

General Information


Serial Number79213672
Word MarkBRIGHTPATH
Filing DateWednesday, April 5, 2017
Status708 - PARTIAL SECTION 71 & 15 ACCEPTED AND ACKNOWLEDGED
Status DateWednesday, June 12, 2024
Registration Number5372344
Registration DateTuesday, January 9, 2018
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, October 24, 2017

Trademark Statements


Description of the Colors ClaimedThe mark consists of the word "BrightPath" in turquoise blue and a yellowish green underscore after the term "BrightPath".
Goods and ServicesPharmaceutical preparations for the prevention and treatment of cancer
Pseudo MarkBRIGHT PATH
Indication of Colors claimedThe color(s) turquoise blue and yellowish green is/are claimed as a feature of the mark.
Goods and Services[ Retail store services or wholesale store services relating to pharmaceutical preparations and medical supplies; retail store services or wholesale store services relating to medical apparatus and instruments ]
Goods and Services[ Medical apparatus and instruments, namely, medical syringe connector ]
Goods and ServicesConducting clinical trials for others; testing, inspection or research of pharmaceuticals

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, August 7, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status CodeG - NOT AVAILABLE
Class Status DateWednesday, June 12, 2024
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status CodeG - NOT AVAILABLE
Class Status DateWednesday, June 12, 2024
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, August 7, 2017
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameBrightPath Biotherapeutics Co., Ltd.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressFukuoka 839-0864
JP

Party NameBrightPath Biotherapeutics Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressJP

Party NameGreenPeptide Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressJP

Trademark Events


Event DateEvent Description
Monday, August 7, 2017ASSIGNED TO EXAMINER
Thursday, August 3, 2017SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, August 4, 2017LIMITATION FROM ORIGINAL APPLICATION ENTERED
Monday, August 7, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, August 14, 2017REFUSAL PROCESSED BY MPU
Wednesday, August 9, 2017NON-FINAL ACTION WRITTEN
Thursday, August 10, 2017NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, August 11, 2017APPLICATION FILING RECEIPT MAILED
Monday, August 14, 2017NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, September 1, 2017REFUSAL PROCESSED BY IB
Thursday, September 7, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, September 11, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, September 7, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, September 8, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, October 4, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 24, 2017PUBLISHED FOR OPPOSITION
Tuesday, October 24, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, November 23, 2017CHANGE OF NAME/ADDRESS REC'D FROM IB
Tuesday, January 9, 2018REGISTERED-PRINCIPAL REGISTER
Monday, January 9, 2023COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Wednesday, October 11, 2023TEAS SECTION 71 & 15 RECEIVED
Monday, April 9, 2018FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Thursday, April 19, 2018FINAL DISPOSITION PROCESSED
Thursday, April 19, 2018FINAL DISPOSITION NOTICE SENT TO IB
Friday, June 1, 2018FINAL DECISION TRANSACTION PROCESSED BY IB
Tuesday, June 11, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, June 12, 2024REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
Wednesday, June 12, 2024NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED